Normal view MARC view ISBD view

The 'empowered client' in vocational rehabilitation: the excluding impact of inclusive strategies. [electronic resource]

By:

van Hal, Lineke B E

Contributor(s):

Producer: 20121116Description: 213-30 p. digitalISSN:

1573-3394

Subject(s):

Online resources:

Available from publisher's website

In: Health care analysis : HCA : journal of health philosophy and policy vol. 20

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

5301 Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.
by Lee, Dong Hyeon
5302 An Abrupt Hepatitis B Seroconversion.
by Lo, Sheng-Ying
5303 Analysis of hepatitis B virus genotypes by restriction fragment length polymorphism.
by Rendón, Julio-C
5304 Hepatitis b virus expression and replication in ovum and the influencing factors.
by Kong, Ying
5305 Does antiplatelet therapy really reduce the risk of hepatocellular carcinoma in hepatitis B patients with antiviral drugs?
by Lo, Gin-Ho
5306 New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus.
by Durantel, David
5307 [Hepatitis B virus infection and its prevention].
by Kumada, Takashi
5308 MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
by Duan, Xiaoqiong
5309 Molecular characterization of AID-mediated reduction of hepatitis B virus transcripts.
by Que, Lusheng
5310 A Misleading Pattern of Serologic Findings During Hepatitis B Virus Infection.
by Ben-Yakov, Gil
5311 Neolithic and medieval virus genomes reveal complex evolution of hepatitis B.
by Krause-Kyora, Ben
5312 2'-Fluoro-6'-methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti-HBV agent, active against drug-resistant HBV mutants.
by Singh, Uma S
5313 [HBV genotyping based on key epitopes of PreS1 antigen and its correlation with genotyping by full-length PreS1 sequencing].
by Zhang, X C
5314 Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.
by Aygen, Bilgehan
5315 Distribution of hepatitis B virus genotypes in Europe and clinical implications: a review.
by Kmet Lunaček, Nina
5316 [A case of resected synchronous hepatocellular and cholangiolocellular carcinoma in the background of resolved hepatitis B virus infection].
by Uchiyama, Takashi
5317 [Reduced frequency of natural killer cell on siglec-7(+) is associated with progression of hepatitis B virus-related cirrhosis].
by Li, Y L
5318 [Determination of reverse transcriptase inhibitor nucleoside analogue resistance profile in pretreatment phase of patients with viral hepatitis B].
by Öksüz, Zehra
5319 Distribution and difference of APOBEC-induced mutations in the TpCpW context of HBV DNA between HCC and non-HCC.
by Ren, FengLing
5320 On the way towards the eradication of chronic hepatitis B.
by Ren, Hong